Current therapeutic approaches for targeting inflammation in depression and cardiovascular disease.

CONCLUSION: Strategies that can mitigate this risk profile are highly needed in the clinical setting, and these particular group of drugs has the possibility of becoming increasingly important in treatment strategies aiming to improve both conditions. PMID: 29512447 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/29512447?dopt=Abstract

Source: Current Drug Metabolism - March 5, 2018 Category: Drugs & Pharmacology Authors: Zuzarte P, Duong A, Figueira ML, Vitali AC, Scola G Tags: Curr Drug Metab Source Type: research